Editorial draft — not for publication yet. Midazolam content needs review by a qualified UK healthcare professional before publication. For advice about your own prescription, contact your prescriber or pharmacist.

Quick answer

Physical dependence and withdrawal have been reported with midazolam, particularly during prolonged sedation in intensive care. Product information says risk increases with dose and duration. This does not mean that a single supervised procedural dose has the same risk profile as a prolonged or repeated course.

Brand-specific product guides for Midazolam: Mydlam. These are separate from the generic guide.

Risk depends on duration and clinical context

Tell the treating team about past dependence or substance-use problems. If treatment is expected to continue, ask how it will be reviewed and how clinicians will reduce or stop it safely when it is no longer needed.

Abrupt stopping after prolonged use can cause withdrawal

After prolonged administration, abrupt discontinuation can cause withdrawal symptoms. Product information includes anxiety, restlessness, sleep disturbance, confusion, mood changes, sensory symptoms and, in severe cases, convulsions. The experience varies and needs a clinician-led plan.

Do not stop or reduce ongoing midazolam treatment yourself. In intensive care, the responsible team should manage any reduction and monitor for withdrawal; after discharge, contact the treating service or prescriber for advice.

Tolerance and misuse are reasons for careful review

Some loss of effect has been reported with long-term ICU sedation. This should be assessed by the clinical team, not addressed by increasing a dose independently. Midazolam is a controlled medicine and should not be shared or used outside the prescribed clinical plan.

If you are worried about dependence, craving, escalating use or withdrawal, tell a healthcare professional honestly. Urgent help is needed for seizures, severe confusion, breathing difficulty or inability to wake.

Need help in the UK? Call 999 for a life-threatening emergency. For urgent medical advice that is not an emergency, contact NHS 111. Ask a pharmacist or prescriber about your specific medicine.

Frequently asked questions

Can midazolam cause dependence?

Physical dependence has been reported, especially during prolonged treatment such as intensive-care sedation. Risk increases with dose and duration; a single supervised dose is a different exposure.

Can I stop midazolam suddenly?

Do not stop prolonged or ongoing treatment abruptly without medical direction. Withdrawal can be serious, including seizures; the treating team should plan any reduction.

Does one dose cause withdrawal?

The strongest product warnings concern prolonged use and duration-related risk. Individual circumstances vary, so ask the clinician about your own exposure rather than applying general statements.

Sources and further reading

This page is based on the following UK sources. Check the leaflet supplied with your own product, as advice can differ between formulations.

Editorial status: Editorial draft — UK clinical and regulatory review required before publication. Sources checked on 3 October 2026.

Related information

Read the Midazolam overview or continue to another topic: